FIMECS
Japan - KanagawaBiotechnology
Focus: FIMECS is a Japanese biotechnology company founded in 2018 specializing in RaPPIDS technology and E3 ligase binder-linker combinations for targeted protein degradation. The company operates as a pre-revenue biotech focused on platform technology development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About FIMECS
AI assessmentNot HiringNo open roles listed right now. Follow FIMECS to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2018
Help build intelligence for FIMECS
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.